Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.
Haematologica. 2022 Sep 1;107(9):2081-2095. doi: 10.3324/haematol.2021.280116.
Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.
持续性细胞减少症是一种具有广泛鉴别诊断的非特异性征象。在遗传性疾病中,导致白血病的细胞减少症需要及时准确的诊断,以确保进行适当的医疗管理,包括在发展为白血病之前进行充分的监测和干细胞移植。我们旨在确定导致儿童持续性细胞减少症的遗传病因的类型和流行率。本研究纳入了在 2016 年至 2019 年间因持续性细胞减少症、骨髓增生异常综合征、再生障碍性贫血或疑似遗传性骨髓衰竭综合征而被转诊至以色列所有儿科血液病中心进行遗传评估的儿童。为了进行变异检测,我们使用了常见突变基因的 Sanger 测序和一个定制的靶向下一代测序面板,该面板涵盖了已知在遗传性细胞减少症中发生突变的 226 个基因;少数患者随后进行了全外显子组测序。共有 189 名持续性细胞减少症患儿接受了遗传评估。在 59 名患者(31.2%)中发现了致病性和可能致病性变异,其中 47 名患者患有白血病易患综合征。这些患者中大多数(32 例,68.1%)患有遗传性骨髓衰竭综合征,9 例(19.1%)患有易致白血病的遗传性血小板减少症,3 例(6.4%)分别患有骨髓增生异常综合征或先天性中性粒细胞减少症的易感性。12 名患者存在无已知白血病易患倾向的细胞减少症,其中 9 名患儿患有遗传性血小板减少症,3 名患儿患有先天性中性粒细胞减少症。总之,在被转诊至持续性细胞减少症的 189 名患儿中,近三分之一患有潜在的遗传性疾病;其中 79.7%存在白血病的种系易感性。对细胞减少症患儿的精确诊断应指导后续的随访和管理计划,并可能对疾病结局产生积极影响。